We are live on ! Find out more
MIG

McGuire Investment Group Portfolio holdings

AUM $1.14B
1-Year Est. Return 79.59%
This Fund
S&P 500
This Quarter Est. Return
+11.67%
1 Year Est. Return
+79.59%
3 Year Est. Return
+184.19%
5 Year Est. Return
+218.18%
10 Year Est. Return
AUM
$336M
AUM Growth
+$47.7M
Cap. Flow
+$17.7M
Cap. Flow %
5.28%
Top 10 Hldgs %
41.67%
Holding
95
New
9
Increased
49
Reduced
22
Closed

Sector Composition

Rank Sector Weight
1 Technology 27.32%
2 Healthcare 26.24%
3 Financials 10.51%
4 Industrials 6.21%
5 Consumer Staples 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OEF icon
76
iShares S&P 100 ETF
OEF
$20.6B
$361K 0.11%
2,316
CDMO
77
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$359K 0.11%
47,131
+11,932
+34% +$90.4K
VGT icon
78
Vanguard Information Technology ETF
VGT
$149B
$321K 0.1%
8,240
-2,144
-21% -$80.7K
QQEW icon
79
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.82B
$301K 0.09%
3,485
EDIT icon
80
Editas Medicine
EDIT
$442M
$296K 0.09%
10,538
-133
-1% -$4.33K
ADBE icon
81
Adobe
ADBE
$105B
$287K 0.09%
586
RTX icon
82
RTX Corp
RTX
$301B
$283K 0.08%
+4,918
New +$299K
BMY icon
83
Bristol-Myers Squibb
BMY
$132B
$275K 0.08%
4,567
+57
+1% +$3.43K
PEP icon
84
PepsiCo
PEP
$190B
$267K 0.08%
1,928
PSI icon
85
Invesco Semiconductors ETF
PSI
$2.5B
$266K 0.08%
10,320
SNY icon
86
Sanofi
SNY
$104B
$252K 0.08%
5,014
+111
+2% +$5.71K
ITA icon
87
iShares US Aerospace & Defense ETF
ITA
$14.7B
$246K 0.07%
3,106
CRSP icon
88
CRISPR Therapeutics
CRSP
$5.17B
$233K 0.07%
2,781
-470
-14% -$41.7K
TBIO
89
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$228K 0.07%
16,749
+6,599
+65% +$102K
LOW icon
90
Lowe's Companies
LOW
$125B
$221K 0.07%
+1,335
New +$206K
SDC
91
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$213K 0.06%
+18,255
New +$168K
IGV icon
92
iShares Expanded Tech-Software Sector ETF
IGV
$14.5B
$207K 0.06%
+3,325
New +$200K
META icon
93
Meta Platforms (Facebook)
META
$1.51T
$205K 0.06%
+782
New +$202K
SGMO
94
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$205K 0.06%
21,710
-1,090
-5% -$11.8K
RGLS
95
DELISTED
Regulus Therapeutics
RGLS
$12K ﹤0.01%
2,400
+400
+20% +$2.63K

Similar funds

McGuire Investment Group's Q3 2020 Portfolio in Review

As of Q3 2020, McGuire Investment Group held 95 positions worth $336M, up 17% from $288M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

McGuire Investment Group deployed $17.7M of net new capital in Q3 2020, opening 9 new positions and adding to 49 existing holdings. Its largest new stake was First Trust NYSE Arca Biotechnology Index Fund: 27,319 shares worth $4.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was FedEx, an estimated $122K trimmed.

  • McGuire Investment Group's largest Q3 2020 buy was First Trust NYSE Arca Biotechnology Index Fund: 27,319 shares worth $4.3M.
  • McGuire Investment Group added most to Johnson & Johnson in Q3 2020, an estimated $2.97M increase.
  • McGuire Investment Group's biggest Q3 2020 reduction was FedEx, cutting an estimated $122K.
  • McGuire Investment Group's ten largest holdings make up 42% of its $336M portfolio in Q3 2020.
  • McGuire Investment Group opened 9 new positions and closed 0 in Q3 2020.
  • McGuire Investment Group's portfolio value rose 17% quarter-over-quarter to $336M.

Based on McGuire Investment Group's 13F filing for Q3 2020, filed 19 Oct 2020.